Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...
The China National Intellectual Property Administration approved the patent covering Hoth’s HT-KIT technology, which is designed to induce apoptosis (programmed cell death) in cancer cells by ...
The Bcl-2 family of proteins, known for their crucial role in regulating apoptosis, present an intriguing opportunity for advancing cancer immunotherapy. Recent studies have highlighted their ...
The field of regulated cell death has undergone a transformative shift with the discovery of novel modalities beyond apoptosis, such as ferroptosis, which ...
Morning Overview on MSN
1 protein block slowed cancer in mice, and it’s a promising target
Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases pushing cancer cells to self-destruct. The work, centered on a molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results